Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Vorinostat × Head & Neck × Clear all

Phase

Status

Completed 7 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3 Lymphoid 3 Dermatologic 2 Thoracic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Head & Neck 1 Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 18 Radiotherapy 10 Cetuximab 10 Carboplatin 10 pembrolizumab 9 Radiotherapy, Intensity-Modulated 8 Nivolumab 8 Fluorouracil 7 Standard of Care 5 durvalumab 4 Paclitaxel 4 epacadostat 3 Radiation 3 Practice Guidelines as Topic 3 Panitumumab 3 Magnetic Resonance Spectroscopy 3 Gene Expression Profiling 3 Drug Therapy 3 Cyclophosphamide 3 Biopsy 3 fludarabine 2 cemiplimab 2 aldesleukin 2 X-Rays 2 Venlafaxine Hydrochloride 2 Thyroxine 2 Surveys and Questionnaires 2 Specimen Handling 2 Radiosurgery 2 Polymerase Chain Reaction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05608369 2025-04-04

HPV

Case Comprehensive Cancer Center

Phase 2 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡